AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
HOOK vs AMZN Fundamental Comparison
| Metric | HOOK | AMZN |
|---|---|---|
| Revenue | $2.0M | $716.9B |
| Net Income | $-15.4M | $77.7B |
| Net Margin | -769.8% | 10.8% |
| ROE | -45.3% | 18.9% |
| ROA | -25.2% | 9.5% |
| Current Ratio | 3.61x | 1.05x |
| Debt/Equity | 0.03x | 0.17x |
| EPS | $-1.23 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HOOK vs AMZN: Frequently Asked Questions
Is HOOK or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. HOOK is rated SELL (45% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does HOOK compare to AMZN fundamentally?
HOOKIPA Pharma Inc. has ROE of -45.3% vs AMAZON COM INC's 18.9%. Net margins are -769.8% vs 10.8% respectively.
Which stock pays higher dividends, HOOK or AMZN?
HOOK has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HOOK or AMZN for long term?
For long-term investing, consider that HOOK has SELL rating with 45% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HOOK vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HOOK vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.